Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.
Clin Transl Sci
; 14(3): 812-819, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-32770730
Full text:
1
Database:
MEDLINE
Main subject:
Pyrimidines
/
Pyrroles
/
Peroxidase
/
Heart Failure
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2021
Type:
Article